We use cookies to personalise content and to analyse our traffic and improve our website. This website relies on sessions to maintain data across web requests. That is done through the use of a ...

Genomics England began as a vessel to execute the UK Government's bold plan to sequence 100,000 whole genomes and incorporate genomic medicine into routine care in the NHS, a feat we achieved in 2018 ...

In this blog, Nadezhda Feliz, Genomics Data Scientist, shares her motivation for working in rare conditions research.

In this explainer episode, we’ve asked John Pullinger, Senior Bio Sample Operations Manager at Genomics England, to explain what it means to go on a diagnostic odyssey. You can also find a series of ...

This blog explores the benefits of applying Large Language Models to extract information from pathology reports, allowing us to curate bespoke ...

At Genomics England, we are committed to transforming health outcomes through innovation in genomics that benefit all patients, regardless of their background. Our Diverse Data Initiative is leading ...

In this series, ‘Genomics 101’, we go back to basics and explore some of the most important topics in genomics. In this blog, we explain what it means to go on a diagnostic odyssey. The term ‘odyssey’ ...

New research has identified a novel mechanism driving osteosarcoma – an aggressive paediatric bone cancer – providing insights to help predict patient outcomes and improve the condition’s management.

The Machine Learning team use machine learning and advanced data analytics to support progress for patients and research partners. Researchers and clinicians detect conditions by using different kinds ...

There is a need for more research in sickle cell Historically, research in sickle cell has not been prioritised. Because of this, there aren’t many treatment options for people living with the ...